nad has been researched along with Hypercholesterolemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egashira, Y; Hirai, S; Koshiguchi, M; Matsuda, H; Sato, M; Yakushiji, M | 1 |
| SOBRA, J | 1 |
1 review(s) available for nad and Hypercholesterolemia
| Article | Year |
|---|---|
[CONGENITAL DEFECTS OF LIPID METABOLISM. CHOLESTEROL METABOLISM AND CURRENT CONCEPTS ON THE FEEDBACK CONTROL OF ITS BIOSYNTHESIS].
Topics: Cholesterol; Coenzyme A; Fatty Acids; Hydrocarbons; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type III; Lipid Metabolism; Lipids; Metabolism; NAD | 1963 |
1 other study(ies) available for nad and Hypercholesterolemia
| Article | Year |
|---|---|
Regulation of rat hepatic α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase, a key enzyme in the tryptophan- NAD pathway, by dietary cholesterol and sterol regulatory element-binding protein-2.
Topics: Animals; Carboxy-Lyases; Cholesterol, Dietary; Gene Expression Regulation, Enzymologic; Hepatocytes; Hydroxycholesterols; Hypercholesterolemia; Liver; Male; Models, Animal; NAD; Rats; Rats, Sprague-Dawley; RNA, Messenger; Simvastatin; Sterol Regulatory Element Binding Protein 2; Tryptophan | 2014 |